Longitude Capital specializes in making venture growth investments in biotechnology and medical technology companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs.
Learn MoreNEA invests in visionary entrepreneurs that are at the helm of current and future industry leaders, fueling the development of technologies that will keep the U.S. at the forefront of innovation.
Learn MoreWorking out of Copenhagen, with affiliates in San Francisco and Boston, Novo Holdings is a world-leading life science investor with a focus on creating long-term value. Novo Holdings invests the wealth of the Foundation in life science investments, which includes investing in life science companies at all stages of development and financial investments, which manages a diversified portfolio of equity and fixed income securities.
Learn MorePivotal bioVenture Partners is a $300 million life sciences venture capital fund established in 2017. Pivotal invests in privately held North American and European companies focused on innovative therapeutic products and platforms to address major unmet medical needs. The company invests at all stages in a company’s evolution, from company creation through mid and late stage clinical development. The Pivotal team brings diverse experience in venture capital, company building, and drug discovery and development to the table in working with entrepreneurs to advance their businesses.
Learn MoreRA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to provide seed funding to startups and to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with fewer capital concerns from inception through commercialization.
Learn MoreCowen Healthcare Investments is dedicated to investing in innovative biotechnology companies that have the potential to transform patient outcomes and reduce healthcare costs.
Learn MoreRock Springs invests primarily in public and private companies across all subsectors of health care, with a focus on identifying innovative solutions for critical unmet needs.
Learn MoreSanofi Ventures invests in early-stage biotech and digital health companies with innovative ideas and transformative new projects of strategic interest to Sanofi.
Learn MoreYou are now signing up to receive email updates and news from Inozyme Pharma. The emails you will receive are not intended to provide you with healthcare advice. Inozyme Pharma will not and does not provide healthcare advice. By registering for this email service, you understand that you are not disclosing any personal, private health information to Inozyme Pharma.
You must be 18 years of age or older to register. By registering to receive these emails, you certify that you are 18 years of age or older and are granting permission to receive general updates and news from Inozyme Pharma.
By providing your information, you agree to allow Inozyme Pharma and its agents to collect the name and email address provided and to be contacted by Inozyme Pharma and its agents using this information in the future. Furthermore, you are agreeing that Inozyme Pharma and its agents may contact you by email. Inozyme Pharma will not sell, rent, or otherwise distribute your name and email address provided.
This site uses cookies as described in our Cookies Policy. To learn more about cookies, including how to disable them, view our Cookies Policy. By clicking the "Accept" or “Close” on this banner, or using our site, you consent to the use of Cookies, unless you disable them.
Accept